Stockscreener 앱 받기
11.63
6.40%
-0.72
시간 외 거래:
11.63
전일 마감가:
$12.35
열려 있는:
$12.35
하루 거래량:
117.87K
Relative Volume:
1.66
시가총액:
$309.28M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-15.68%
1개월 성능:
-23.49%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$11.45
$12.85
1주일 범위
$11.45
$13.99
52주 변동 폭
$11.45
$17.19
Carlsmed Inc Stock (CARL) Company Profile
명칭
Carlsmed Inc
전화
858-295-9290
주소
1800 ASTON AVENUE, CARLSBAD
CARL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
11.63 | 328.42M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
219.53 | 36.69B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
62.36 | 10.51B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.29 | 8.34B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
91.07 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
38.40 | 6.75B | 11.99B | 24.18M | 234.31M | 0.2956 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-18 | 개시 | BTIG Research | Buy |
| 2025-08-18 | 개시 | BofA Securities | Buy |
| 2025-08-18 | 개시 | Goldman | Buy |
| 2025-08-18 | 개시 | Piper Sandler | Overweight |
| 2025-08-18 | 개시 | Truist | Buy |
Carlsmed Inc 주식(CARL)의 최신 뉴스
What is the current Price Target and Forecast for Carlsmed, Inc. (CARL) - Zacks Investment Research
Carlsmed Debuts AI-based Custom Implants for Cervical Spine Surgery - San Diego Business Journal
Critical Comparison: Longevity Health (NASDAQ:XAGE) vs. Carlsmed (NASDAQ:CARL) - Defense World
Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference - The Manila Times
Inside the J.P. Morgan healthcare event Carlsmed is joining in 2026 - Stock Titan
BTIG Reiterates Carlsmed (CARL) Buy Recommendation - Nasdaq
Carlsmed stock holds Buy rating at BTIG as aprevo Cervical launch shows promise By Investing.com - Investing.com South Africa
Carlsmed stock holds Buy rating at BTIG as aprevo Cervical launch shows promise - Investing.com Nigeria
CARLSMED, INC. (CARL) Competitors - Meyka
CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery - Yahoo Finance
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting - Ortho Spine News
Carlsmed launches personalized cervical fusion implant system By Investing.com - Investing.com Nigeria
Carlsmed Launches Aprevo Platform for Cervical Fusion Surgeries - marketscreener.com
Carlsmed launches personalized cervical fusion implant system - Investing.com
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting - GlobeNewswire Inc.
Comparing Bioventus (NASDAQ:BVS) & Carlsmed (NASDAQ:CARL) - Defense World
Carlsmed, Inc. Stock (I82)Quote Deutsche Boerse AG - MarketScreener
Carlsmed, Inc.: Dividend historical data and projections - MarketScreener
Carlsmed, Inc.: Financial Data Forecasts Estimates and Expectations | I82 | US14280C1053 - MarketScreener
Carlsmed, Inc.: Revenue and Earnings Analysts Forecasts Revisions | I82 | US14280C1053 - MarketScreener
Carlsmed Stock: Back To Where We Started (NASDAQ:CARL) - Seeking Alpha
Discontinued operations of Carlsmed, Inc. – FWB:I82 - TradingView
Carlsmed, Inc. Cash Flow – FWB:I82 - TradingView
Basic earnings per share (basic EPS) of Carlsmed, Inc. – FWB:I82 - TradingView
Carlsmed Reports Strong Q3 Growth and Raises Guidance - MSN
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Carlsmed (NASDAQ:CARL) Raised to Hold at Wall Street Zen - MarketBeat
Bioventus (NASDAQ:BVS) & Carlsmed (NASDAQ:CARL) Critical Contrast - Defense World
Truist Financial Reaffirms Buy Rating for Carlsmed (NASDAQ:CARL) - MarketBeat
BTIG Research Increases Carlsmed (NASDAQ:CARL) Price Target to $24.00 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Carlsmed, Inc. (CARL), Brookdale Senior Living (BKD) and Eton Pharmaceuticals (ETON) - The Globe and Mail
Carlsmed (NASDAQ:CARL) Announces Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
BTIG Maintains Carlsmed (CARL) Buy Recommendation - Nasdaq
Carlsmed stock price target raised to $24 by BTIG on strong Q3 results - Investing.com South Africa
Earnings call transcript: Carlsmed Q3 2025 sees 98% revenue growth By Investing.com - Investing.com Nigeria
Earnings call transcript: Carlsmed Q3 2025 sees 98% revenue growth - Investing.com
Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance - Ortho Spine News
Carlsmed Secures $60 Million Credit Facility Amendment - MSN
Carlsmed, Inc. (CARL) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Carlsmed, Inc. (NASDAQ:CARL) Sees Significant Decrease in Short Interest - MarketBeat
Carlsmed, Inc. (CARL) Stock Price, News, Quote & History - Yahoo! Finance Canada
carlsmed, inc. Earnings dates - RTTNews
Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025 - The Manila Times
Carlsmed Inc (CARL) 재무 분석
Carlsmed Inc (CARL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Carlsmed Inc 주식 (CARL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Sidow Kevin | Director |
Jul 24 '25 |
Buy |
15.00 |
13,333 |
199,995 |
59,566 |
| Mittendorff Robert II | Director |
Jul 24 '25 |
Buy |
15.00 |
1,333,333 |
19,999,995 |
5,013,839 |
| ROOT JONATHAN D | Director |
Jul 24 '25 |
Buy |
15.00 |
466,666 |
6,999,990 |
483,999 |
| YOUNG PHILIP M | Director |
Jul 24 '25 |
Buy |
15.00 |
59,999 |
899,985 |
53,333 |
1.81%
0.99%
자본화:
|
볼륨(24시간):